| abstract |
Disclosed are compounds of the general formula: <IMAGE> wherein R1 is amino, an acylated amino or a protected amino group, X is hydrogen or methoxy, and R' is hydrogen, R or R4 wherein R is an organic residue attached to the azetidine ring through a carbon atom therein and R4 is azido, a halogen, an amino group which may optionally be acylated or a group of the formula -OR5, <IMAGE> or -S-S-R5 wherein R5 is an organic residue and n is 0, 1 or 2, and pharmaceutically acceptable salts and esters thereof. The compounds have antimicrobial and/or beta -lactamase-inhibitory activity and are of value as drugs for human beings and domesticated animals. |